Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Mol Imaging. 2010 Aug;9(4):175-91.
Owing to increased needs for positron emission tomography (PET), high demands for a wide variety of radiolabeled compounds will have to be met by exploiting novel radiochemistry and engineering technologies to improve the production and development of PET probes. The application of microfluidic reactors to perform radiosyntheses is currently attracting a great deal of interest because of their potential to deliver many advantages over conventional labeling systems. Microfluidics-based radiochemistry can lead to the use of smaller quantities of precursors, accelerated reaction rates, and easier purification processes with greater yield and higher specific activity of desired probes. Several proof-of-principle examples along with the basics of device architecture and operation and the potential limitations of each design are discussed. Along with the concept of radioisotope distribution from centralized cyclotron facilities to individual imaging centers and laboratories ("decentralized model"), an easy-to-use, stand-alone, flexible, fully automated, radiochemical microfluidic platform can provide simpler and more cost-effective procedures for molecular imaging using PET.
由于正电子发射断层扫描(PET)的需求增加,必须利用新的放射化学和工程技术来满足各种放射性标记化合物的广泛需求,以改进 PET 探针的生产和开发。由于微流控反应器在放射合成方面具有许多优于传统标记系统的潜在优势,因此目前引起了极大的兴趣。基于微流控的放射化学可以减少前体的用量,加快反应速度,并简化纯化过程,从而提高所需探针的产量和比活度。本文讨论了一些原理验证示例,以及器件结构和操作的基础,以及每种设计的潜在局限性。除了从集中的回旋加速器设施到各个成像中心和实验室的放射性同位素分配的概念(“分散模型”)之外,易于使用、独立、灵活、全自动、放射化学微流控平台可以为使用 PET 的分子成像提供更简单、更具成本效益的程序。